The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2017

Filed:

Oct. 05, 2012
Applicant:

Hanmi Science Co., Ltd., Hwaseong-si, Gyeonggi-do, KR;

Inventors:

Dae Jin Kim, Hwaseong-si, KR;

Byung Sun Lee, Seoul, KR;

Sung Hwan Hong, Seoul, KR;

Yong Ho Huh, Seoul, KR;

Sung Youb Jung, Suwon-si, KR;

Se Chang Kwon, Seoul, KR;

Assignee:

HANMI SCIENCE CO., LTD., Hwaseong-shi, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/36 (2006.01); A61K 38/16 (2006.01); A61K 48/00 (2006.01); A61P 7/04 (2006.01); A61K 38/48 (2006.01); C12N 9/64 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4846 (2013.01); A61K 47/4843 (2013.01); C12N 9/6437 (2013.01); A61K 48/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/31 (2013.01); C07K 2319/50 (2013.01);
Abstract

A blood coagulation factor VII derivative, a blood coagulation factor VIIa derivative, FacVII and FacVIIa conjugates are prepared by linking a polymer capable of extending the blood half-life to the derivative. FacVII and VIIa complexes each prepared by linking a carrier to the conjugate, genes encoding the FacVII and FacVIIa derivatives, expression vectors comprising the genes, transformants introduced with the expression vectors, a method for preparing the FacVII and FacVIIa derivatives using the transformants, a method for preparing the FacVIIa conjugate and complex, a FacVIIa complex prepared by the method, a pharmaceutical composition for the prevention or treatment of hemophilia comprising the derivative, conjugate, or complex as an active ingredient, and a pharmaceutical composition for blood coagulation comprising the derivative, conjugate, or complex as an active ingredient are described.


Find Patent Forward Citations

Loading…